Warfarin Compared to Aspirin for Prevention of Arterial Thromboembolism in Atrial Fibrillation

Autor:	G. Hellström, C L Franke, Julien Bogousslavsky, Kjell Asplund, Didier Leys, M. Ferrandiz, Michael Daras, G. L. Lenzi, Secundino López-Pousa, Takenori Yamaguchi, P Rondepierre, V. Di Piero, Louis R. Caplan, A. Rudehill, B. Marino, A. Molins, Patrizia Pantano, D. Genís, Theodor Landis, O. Fustioni, A. Nègre, Stephen Marks, Alan J. Tuchman, C. Lindquist, E. de Cendra, Masahiro Yasaka, Barbara Tettenborn, Jean-Christophe Stauffer, Takashi Tsuchiya, Ralf W. Baumgartner, M.J.J. Buscher, Carlos Cantú, Franco Regli, G. Soto Ares, Antonio Dávalos, R. Di Cori, J.W.J. van Wersch, G.F. Pezzoli, Franco Giubilei, Nils Wahlgren, O. Godefroy, Bernard Nater
Rok vydání:	1992
Předmět:	Aspirin medicine.medical_specialty business.industry Warfarin Atrial fibrillation medicine.disease Neurology Internal medicine medicine Cardiology Neurology (clinical) Cardiology and Cardiovascular Medicine business medicine.drug
Zdroj:	Cerebrovascular Diseases. 2:332-341
ISSN:	1421-9786 1015-9770
DOI:	10.1159/000109040
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5c520214f6e736c1189013ff1d1baeaf https://doi.org/10.1159/000109040 Zobrazit plný text záznamu